Zobrazeno 1 - 10
of 582
pro vyhledávání: '"Antonio Anzueto"'
Autor:
Antonio Anzueto, Mark Cohen, Andres L. Echazarreta, Gehan Elassal, Irma Godoy, Rafael Paramo, Abdullah Sayiner, Carlos A. Torres-Duque, Sudeep Acharya, Bhumika Aggarwal, Hakan Erkus, Gur Levy
Publikováno v:
Pulmonary Therapy, Vol 10, Iss 1, Pp 69-84 (2023)
Abstract Introduction The objective of this Delphi study was to understand and assess the level of consensus among respiratory experts on the clinical application of GOLD 2023 recommendations in management of patients with chronic obstructive pulmona
Externí odkaz:
https://doaj.org/article/97d02ba387af40f295627763c2848cf4
Autor:
Edwin K. Silverman, Arthur Y. Kim, Barry J. Make, Elizabeth A. Regan, Jarrett D. Morrow, Craig P. Hersh, James O’Brien, James D. Crapo, Nadia N. Hansel, Gerard Criner, Eric L. Flenaugh, Douglas Conrad, Richard Casaburi, Russell P. Bowler, Nicola A. Hanania, R. Graham Barr, Surya P. Bhatt, Frank C. Sciurba, Antonio Anzueto, MeiLan K. Han, Charlene E. McEvoy, Alejandro P. Comellas, Dawn L. DeMeo, Richard Rosiello, Jeffrey L. Curtis, Tricia Uchida, Carla Wilson, P. Pearl O’Rourke
Publikováno v:
npj Genomic Medicine, Vol 8, Iss 1, Pp 1-7 (2023)
Abstract The consequences of returning infectious pathogen test results identified incidentally in research studies have not been well-studied. Concerns include identification of an important health issue for individuals, accuracy of research test re
Externí odkaz:
https://doaj.org/article/a034853435794deda933ce8b99d3be0f
Publikováno v:
European Respiratory Review, Vol 32, Iss 170 (2023)
Augmentation therapy with intravenous alpha-1 antitrypsin is the only specific treatment for alpha-1 antitrypsin deficiency (AATD)-associated emphysema. This treatment has been available and remained basically unchanged for more than 35 years, but ma
Externí odkaz:
https://doaj.org/article/8cceef5527064f92b2756436c9df08e8
Autor:
Mario Cazzola, Clive P. Page, Jadwiga A. Wedzicha, Bartolome R. Celli, Antonio Anzueto, Maria Gabriella Matera
Publikováno v:
Respiratory Research, Vol 24, Iss 1, Pp 1-13 (2023)
Abstract Background Oxidative stress and persistent airway inflammation are thought to be important contributors to the development of chronic obstructive pulmonary disease (COPD). This review summarizes the evidence for targeting oxidative stress an
Externí odkaz:
https://doaj.org/article/6bba8031d0d8401ab5e9891c5158f396
Autor:
Sunil K. Ahuja, Muthu Saravanan Manoharan, Grace C. Lee, Lyle R. McKinnon, Justin A. Meunier, Maristella Steri, Nathan Harper, Edoardo Fiorillo, Alisha M. Smith, Marcos I. Restrepo, Anne P. Branum, Matthew J. Bottomley, Valeria Orrù, Fabio Jimenez, Andrew Carrillo, Lavanya Pandranki, Caitlyn A. Winter, Lauryn A. Winter, Alvaro A. Gaitan, Alvaro G. Moreira, Elizabeth A. Walter, Guido Silvestri, Christopher L. King, Yong-Tang Zheng, Hong-Yi Zheng, Joshua Kimani, T. Blake Ball, Francis A. Plummer, Keith R. Fowke, Paul N. Harden, Kathryn J. Wood, Martin T. Ferris, Jennifer M. Lund, Mark T. Heise, Nigel Garrett, Kristen R. Canady, Salim S. Abdool Karim, Susan J. Little, Sara Gianella, Davey M. Smith, Scott Letendre, Douglas D. Richman, Francesco Cucca, Hanh Trinh, Sandra Sanchez-Reilly, Joan M. Hecht, Jose A. Cadena Zuluaga, Antonio Anzueto, Jacqueline A. Pugh, South Texas Veterans Health Care System COVID-19 team, Brian K. Agan, Robert Root-Bernstein, Robert A. Clark, Jason F. Okulicz, Weijing He
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-31 (2023)
Abstract Some people remain healthier throughout life than others but the underlying reasons are poorly understood. Here we hypothesize this advantage is attributable in part to optimal immune resilience (IR), defined as the capacity to preserve and/
Externí odkaz:
https://doaj.org/article/2d05c47c46834fc38503fbfb37c7eb1f
Autor:
Behrooz Mamandipoor, Fernando Frutos-Vivar, Oscar Peñuelas, Richard Rezar, Konstantinos Raymondos, Alfonso Muriel, Bin Du, Arnaud W. Thille, Fernando Ríos, Marco González, Lorenzo del-Sorbo, Maria del Carmen Marín, Bruno Valle Pinheiro, Marco Antonio Soares, Nicolas Nin, Salvatore M. Maggiore, Andrew Bersten, Malte Kelm, Raphael Romano Bruno, Pravin Amin, Nahit Cakar, Gee Young Suh, Fekri Abroug, Manuel Jibaja, Dimitros Matamis, Amine Ali Zeggwagh, Yuda Sutherasan, Antonio Anzueto, Bernhard Wernly, Andrés Esteban, Christian Jung, Venet Osmani
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Mechanical Ventilation (MV) is a complex and central treatment process in the care of critically ill patients. It influences acid–base balance and can also cause prognostically relevant biotrauma by generating forces and liberat
Externí odkaz:
https://doaj.org/article/b6cc1fbe0d0e4731af222028bdc5c7c0
Autor:
Sandeep Bansal, Martin Anderson, Antonio Anzueto, Nicola Brown, Chris Compton, Thomas C. Corbridge, David Erb, Catherine Harvey, Morrys C. Kaisermann, Mitchell Kaye, David A. Lipson, Neil Martin, Chang-Qing Zhu, Alberto Papi
Publikováno v:
npj Primary Care Respiratory Medicine, Vol 31, Iss 1, Pp 1-9 (2021)
Abstract Chronic obstructive pulmonary disease (COPD) treatment guidelines do not currently include recommendations for escalation directly from monotherapy to triple therapy. This 12-week, double-blind, double-dummy study randomized 800 symptomatic
Externí odkaz:
https://doaj.org/article/dac6017c105b4a2b8e947907b8317115
Autor:
Antonio Anzueto, Marc Miravitlles
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-16 (2020)
Abstract Background Bronchodilators are the mainstay of pharmacological treatment in chronic obstructive pulmonary disease (COPD), and long-acting muscarinic antagonist (LAMA) monotherapy is recommended as initial treatment for Global Initiative for
Externí odkaz:
https://doaj.org/article/4ab5fdc0b9ce4b2e9f4c93d8ec87453c
Autor:
Donald P. Tashkin, Marc Miravitlles, Bartolomé R. Celli, Norbert Metzdorf, Achim Mueller, David M. G. Halpin, Antonio Anzueto
Publikováno v:
Respiratory Research, Vol 19, Iss 1, Pp 1-11 (2018)
Abstract Background Use of inhaled corticosteroids (ICS) increases the risk of pneumonia in chronic obstructive pulmonary disease (COPD), but the magnitude of risk with different ICS remains unclear. Methods A post hoc analysis of the 4-year UPLIFT®
Externí odkaz:
https://doaj.org/article/d1385d7d775049c4ab01919f47a8c26b
Autor:
Nicola A. Hanania, Alberto Papi, Antonio Anzueto, Fernando J. Martinez, Kimberly A. Rossman, Christy S. Cappelletti, Elizabeth A. Duncan, Jack S. Nyberg, Paul M. Dorinsky
Publikováno v:
ERJ Open Research, Vol 6, Iss 2 (2020)
Inhaled corticosteroid/long-acting β2-agonist combination therapy is a recommended treatment option for patients with chronic obstructive pulmonary disease (COPD) and increased exacerbation risk, particularly those with elevated blood eosinophil lev
Externí odkaz:
https://doaj.org/article/bfb333f45e934420a33745ff729dd3a6